Mortality data is a critical component of aggregated RWD when trying to identify vulnerable populations for early intervention, measure long term outcomes in clinical trials, or create survival curves for oncology studies. Any time new data is appended to deidentified RWD, it is important to consider the privacy implications and protection of that deidentified status: we discuss how to navigate these challenges with Shubh Sinha and the team at Integral in this new article: Navigating the Challenges of Utilizing Mortality Data

Read the full article to learn about how adding mortality data to your deidentified data lake, while preserving patient privacy, is effortless when working with Veritas Data Research and Integral.